Negera Edessa, Walker Stephen L, Bobosha Kidist, Howe Rawleigh, Aseffa Abraham, Dockrell Hazel M, Lockwood Diana N
London School of Hygiene and Tropical Medicine (LSHTM), Faculty of Infectious Tropical Diseases, London, United Kingdom.
Armauer Hansen Research Institute (AHRI), Addis Ababa, Ethiopia.
PLoS Negl Trop Dis. 2017 Oct 9;11(10):e0006001. doi: 10.1371/journal.pntd.0006001. eCollection 2017 Oct.
Leprosy is a disease caused by Mycobacterium leprae where the clinical spectrum correlates with the patient immune response. Erythema Nodosum Leprosum (ENL) is an immune-mediated inflammatory complication, which causes significant morbidity in affected leprosy patients. The underlying cause of ENL is not conclusively known. However, immune-complexes and cell-mediated immunity have been suggested in the pathogenesis of ENL. The aim of this study was to investigate the regulatory T-cells in patients with ENL. Forty-six untreated patients with ENL and 31 non-reactional lepromatous leprosy (LL) patient controls visiting ALERT Hospital, Ethiopia were enrolled to the study. Blood samples were obtained before, during and after prednisolone treatment of ENL cases. Peripheral blood mononuclear cells (PBMCs) were isolated and used for immunophenotyping of regulatory T-cells by flow cytometry. Five markers: CD3, CD4 or CD8, CD25, CD27 and FoxP3 were used to define CD4+ and CD8+ regulatory T-cells. Clinical and histopathological data were obtained as supplementary information. All patients had been followed for 28 weeks. Patients with ENL reactions had a lower percentage of CD4+ regulatory T-cells (1.7%) than LL patient controls (3.8%) at diagnosis of ENL before treatment. After treatment, the percentage of CD4+regulatory T-cells was not significantly different between the two groups. The percentage of CD8+ regulatory T-cells was not significantly different in ENL and LL controls before and after treatment. Furthermore, patients with ENL had higher percentage of CD4+ T-ells and CD4+/CD8+ T-cells ratio than LL patient controls before treatment. The expression of CD25 on CD4+ and CD8+ T-cells was not significantly different in ENL and LL controls suggesting that CD25 expression is not associated with ENL reactions while FoxP3 expression on CD4+ T-cells was significantly lower in patients with ENL than in LL controls. We also found that prednisolone treatment of patients with ENL reactions suppresses CD4+ T-cell but not CD8+ T-cell frequencies. Hence, ENL is associated with lower levels of T regulatory cells and higher CD4+/CD8+ T-cell ratio. We suggest that this loss of regulation is one of the causes of ENL.
麻风病是一种由麻风分枝杆菌引起的疾病,其临床症状与患者的免疫反应相关。结节性红斑型麻风(ENL)是一种免疫介导的炎症并发症,会给受影响的麻风病患者带来严重的发病率。ENL的根本原因尚未完全明确。然而,免疫复合物和细胞介导的免疫反应在ENL的发病机制中被提及。本研究的目的是调查ENL患者体内的调节性T细胞。46名未经治疗的ENL患者以及31名非反应性瘤型麻风(LL)患者作为对照,他们均前往埃塞俄比亚的ALERT医院就诊,并被纳入该研究。在对ENL患者进行泼尼松龙治疗之前、治疗期间和治疗之后采集血样。分离外周血单个核细胞(PBMC),并通过流式细胞术对调节性T细胞进行免疫表型分析。使用五个标志物:CD3、CD4或CD8、CD25、CD27和FoxP3来定义CD4 +和CD8 +调节性T细胞。获取临床和组织病理学数据作为补充信息。所有患者均被随访28周。在治疗前ENL诊断时,ENL反应患者的CD4 +调节性T细胞百分比(1.7%)低于LL患者对照组(3.8%)。治疗后,两组之间CD4 +调节性T细胞百分比无显著差异。治疗前后,ENL组和LL对照组中CD8 +调节性T细胞百分比无显著差异。此外,治疗前,ENL患者的CD4 + T细胞百分比和CD4 + / CD8 + T细胞比值高于LL患者对照组。ENL组和LL对照组中CD4 +和CD8 + T细胞上CD25的表达无显著差异,这表明CD25表达与ENL反应无关,而ENL患者CD4 + T细胞上FoxP3的表达显著低于LL对照组。我们还发现,对有ENL反应的患者进行泼尼松龙治疗会抑制CD4 + T细胞频率,但不会抑制CD8 + T细胞频率。因此,ENL与较低水平的调节性T细胞以及较高的CD4 + / CD8 + T细胞比值相关。我们认为这种调节功能的丧失是ENL的病因之一。